Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun:2:100016.
doi: 10.1016/j.bionps.2020.100016. Epub 2020 May 12.

Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development

Affiliations

Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development

K Juston Osborne et al. Biomark Neuropsychiatry. 2020 Jun.

Abstract

Motor abnormalities (e.g., dyskinesia, psychomotor slowing, neurological soft signs) are core features of schizophrenia that occur independent of drug treatment and are associated with the genetic vulnerability and pathophysiology for the illness. Among this list, psychomotor slowing in particular is one of the most consistently observed and robust findings in the field. Critically, psychomotor slowing may serve as a uniquely promising endophenotype and/or biomarker for schizophrenia considering it is frequently observed in those with genetic vulnerability for the illness, predicts transition in subjects at high-risk for the disorder, and is associated with symptoms and recovery in patients. The purpose of the present review is to provide an overview of the history of psychomotor slowing in psychosis, discuss its possible neural underpinnings, and review the current literature supporting slowing as a putative endophenotype and/or biomarker for the illness. This review summarizes substantial evidence from a diverse array of methodologies and research designs that supports the notion that psychomotor slowing not only reflects genetic vulnerability, but is also sensitive to disease processes and the pathophysiology of the illness. Furthermore, there are unique deficits across the cognitive (prefix "psycho") and motor execution (root word "motor") aspects of slowing, with cognitive processes such as planning and response selection being particularly affected. These findings suggest that psychomotor slowing may serve as a promising endophenotype and biomarker for schizophrenia that may prove useful for identifying individuals at greatest risk and tracking the course of the illness and recovery.

Keywords: Biomarker; Catatonia; Clinical High-Risk; Endophenotype; Psychomotor; Psychosis; Schizophrenia; Slowing.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
A conceptual model of psychomotor slowing in psychosis.

References

    1. Aas M, Dazzan P, Mondelli V, Melle I, Murray RM, & Pariante CM (2014). A systematic review of cognitive function in first-episode psychosis, including a discussion on childhood trauma, stress, and inflammation. Frontiers in psychiatry, 4, 182. - PMC - PubMed
    1. Atkinson RC, & Shiffrin RM (1968). Human memory: A proposed system and its control processes Psychology of learning and motivation (Vol. 2, pp. 89–195): Elsevier.
    1. Barany DA, Della-Maggiore V, Viswanathan S, Cieslak M, & Grafton ST (2014). Feature interactions enable decoding of sensorimotor transformations for goal-directed movement. Journal of Neuroscience, 34(20), 6860–6873. - PMC - PubMed
    1. Barch DM, Moore H, Nee DE, Manoach DS, & Luck SJ (2011). CNTRICS imaging biomarkers selection: Working memory. Schizophrenia Bulletin, 38(1), 43–52. - PMC - PubMed
    1. Beer MD (1995). Psychosis: from mental disorder to disease concept. History of Psychiatry, 6(22), 177–200. - PubMed